HCA Healthcare (NYSE:HCA) Upgraded to Buy by Goldman Sachs Group

Goldman Sachs Group upgraded shares of HCA Healthcare (NYSE:HCA) from a neutral rating to a buy rating in a research report sent to investors on Wednesday morning, 24/7 WallStreet reports. They currently have $160.00 price target on the stock, up from their previous price target of $147.00.

A number of other equities research analysts also recently commented on HCA. Barclays set a $24.00 target price on Tenet Healthcare and gave the company a hold rating in a research report on Wednesday, April 17th. Zacks Investment Research upgraded GALP ENERGIA SG/ADR from a sell rating to a hold rating in a research report on Monday, May 27th. Jefferies Financial Group set a $158.00 target price on HCA Healthcare and gave the company a buy rating in a research report on Wednesday, April 17th. Deutsche Bank cut Hilton Hotels from a buy rating to a hold rating and set a $92.60 price objective for the company. in a research note on Wednesday, May 1st. They noted that the move was a valuation call. Finally, Raymond James set a $86.00 price objective on Gilead Sciences and gave the company a buy rating in a research note on Tuesday, April 23rd. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and nineteen have issued a buy rating to the stock. The company currently has an average rating of Buy and a consensus price target of $149.87.

NYSE:HCA traded up $1.97 on Wednesday, reaching $138.65. The company’s stock had a trading volume of 1,412,800 shares, compared to its average volume of 1,731,572. HCA Healthcare has a 12-month low of $105.22 and a 12-month high of $147.42. The firm has a market capitalization of $47.02 billion, a price-to-earnings ratio of 14.19, a price-to-earnings-growth ratio of 1.11 and a beta of 0.80. The company has a 50 day moving average of $129.68.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, April 30th. The company reported $2.97 EPS for the quarter, beating the Zacks’ consensus estimate of $2.31 by $0.66. HCA Healthcare had a negative return on equity of 112.65% and a net margin of 7.71%. The company had revenue of $12.52 billion for the quarter, compared to the consensus estimate of $12.34 billion. During the same quarter in the previous year, the business earned $3.18 earnings per share. The company’s revenue for the quarter was up 9.6% on a year-over-year basis. Research analysts expect that HCA Healthcare will post 10.4 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Monday, June 3rd were paid a $0.40 dividend. The ex-dividend date of this dividend was Friday, May 31st. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.15%. HCA Healthcare’s payout ratio is presently 16.38%.

In related news, insider Jon M. Foster sold 44,281 shares of the business’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of $122.28, for a total transaction of $5,414,680.68. Following the completion of the transaction, the insider now directly owns 96,052 shares of the company’s stock, valued at approximately $11,745,238.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 2.70% of the company’s stock.

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sontag Advisory LLC acquired a new position in HCA Healthcare during the 4th quarter worth $26,000. Financial Gravity Wealth Inc. acquired a new position in HCA Healthcare during the 1st quarter worth $47,000. Valeo Financial Advisors LLC acquired a new position in HCA Healthcare during the 1st quarter worth $66,000. Rational Advisors LLC grew its stake in HCA Healthcare by 5,118.2% during the 1st quarter. Rational Advisors LLC now owns 574 shares of the company’s stock worth $75,000 after purchasing an additional 563 shares in the last quarter. Finally, Cornerstone Advisors Inc. grew its stake in HCA Healthcare by 19.6% during the 1st quarter. Cornerstone Advisors Inc. now owns 587 shares of the company’s stock worth $77,000 after purchasing an additional 96 shares in the last quarter. 70.23% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

See Also: What is the Moving Average Convergence Divergence (MACD) oscillator?

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.